Dynamic Changes in the Extracellular Matrix in Primary, Metastatic, and Recurrent Ovarian Cancers

· 2022-11-25

Cancer-associated fibroblasts (CAFs) and their extracellular matrix are active participants in cancer progression. While it is known that functionally different subpopulations of CAFs co-exist in ovarian cancer, it is unclear whether certain CAF subsets are enriched during metastatic progression and/or chemotherapy. Using computational image analyses of patient-matched primary high-grade serous ovarian carcinomas, synchronous pre-chemotherapy metastases, and metachronous post-chemotherapy metastases from 42 patients, we documented the dynamic spatiotemporal changes in the extracellular matrix, fibroblasts, epithelial cells, immune cells, and CAF subsets expressing different extracellular matrix components. Among the different CAF subsets, COL11A1+ CAFs were associated with linearized collagen fibers and exhibited the greatest enrichment in pre- and post-chemotherapy metastases compared to matched primary tumors. Although pre- and post-chemotherapy metastases were associated with increased CD8+ T cell infiltration, the infiltrate was not always evenly distributed between the stroma and cancer cells, leading to an increased frequency of the immune-excluded phenotype where the majority of CD8+ T cells are present in the tumor stroma but absent from the tumor parenchyma. Overall, most of the differences in the tumor microenvironment were observed between primary tumors and metastases, while fewer differences were observed between pre- and post-treatment metastases. These data suggest that the tumor microenvironment is largely determined by the primary vs. metastatic location of the tumor while chemotherapy does not have a significant impact on the host microenvironment.

Journal
Cells
Funding

BLRD VA

I01 BX004974

NIH HHS

R01 CA208753

NIH HHS

UL1TR00188

NCI NIH HHS

P30 CA016042

NCI NIH HHS

R01 CA208753

NCATS NIH HHS

UL1 TR001881

United States Department of Veterans Affairs

VA-ORD I01 BX004974

United States Department of Veterans Affairs

NIH R01 CA208753

United States Department of Veterans Affairs

No. W81XWH2210631

United States Department of Veterans Affairs

UL1TR00188

United States Department of Veterans Affairs

no.07/010/SDU/10-21-01

Office of the Assistant Secretary of Defense for Health Affairs

VA-ORD I01 BX004974

Office of the Assistant Secretary of Defense for Health Affairs

NIH R01 CA208753

Office of the Assistant Secretary of Defense for Health Affairs

No. W81XWH2210631

Office of the Assistant Secretary of Defense for Health Affairs

UL1TR00188

Office of the Assistant Secretary of Defense for Health Affairs

no.07/010/SDU/10-21-01

Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health Pilot Research Project NCATS UCLA CTSI

VA-ORD I01 BX004974

Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health Pilot Research Project NCATS UCLA CTSI

NIH R01 CA208753

Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health Pilot Research Project NCATS UCLA CTSI

No. W81XWH2210631

Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health Pilot Research Project NCATS UCLA CTSI

UL1TR00188

Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health Pilot Research Project NCATS UCLA CTSI

no.07/010/SDU/10-21-01

Sandy Rollman Ovarian Cancer Foundation

VA-ORD I01 BX004974

Sandy Rollman Ovarian Cancer Foundation

NIH R01 CA208753

Sandy Rollman Ovarian Cancer Foundation

No. W81XWH2210631

Sandy Rollman Ovarian Cancer Foundation

UL1TR00188

Sandy Rollman Ovarian Cancer Foundation

no.07/010/SDU/10-21-01

Mary Kay Foundation

VA-ORD I01 BX004974

Mary Kay Foundation

NIH R01 CA208753

Mary Kay Foundation

No. W81XWH2210631

Mary Kay Foundation

UL1TR00188

Mary Kay Foundation

no.07/010/SDU/10-21-01

Annenberg Foundation.

VA-ORD I01 BX004974

Annenberg Foundation.

NIH R01 CA208753

Annenberg Foundation.

No. W81XWH2210631

Annenberg Foundation.

UL1TR00188

Annenberg Foundation.

no.07/010/SDU/10-21-01

Silesian University of Technology

VA-ORD I01 BX004974

Silesian University of Technology

NIH R01 CA208753

Silesian University of Technology

No. W81XWH2210631

Silesian University of Technology

UL1TR00188

Silesian University of Technology

no.07/010/SDU/10-21-01